The AlphaLISA™ SureFire® Ultra™ Human and Mouse Total STAT2 assay is a sandwich immunoassay for quantitative detection of total STAT2 in cellular lysates using Alpha Technology.
| Feature | Specification |
|---|---|
| Application | Cell Signaling |
| Protocol Time | 2h at RT |
| Sample Volume | 10 µL |
The AlphaLISA™ SureFire® Ultra™ Human and Mouse Total STAT2 assay is a sandwich immunoassay for quantitative detection of total STAT2 in cellular lysates using Alpha Technology.
Loading...
Signal Transducer and Activator of Transcription 2 (STAT2) is a transcription factor that primarily mediates type I and type III interferon (IFN) signaling, playing a central role in establishing antiviral defenses. Upon IFN stimulation, receptor‑associated JAK1 and TYK2 phosphorylate STAT2 (and STAT1). Phosphorylated STAT2 heterodimerizes with STAT1 and associates with IRF9 to form the ISGF3 complex, which binds interferon‑stimulated response elements (ISREs) to induce interferon‑stimulated genes (ISGs), including OAS, PKR (EIF2AK2), and MX1/MX2.
Unlike several other STATs, STAT2 does not bind DNA as a homodimer and exerts most transcriptional functions within ISGF3. In STAT1‑limited contexts, STAT2 can partner with IRF9 to drive a STAT2–IRF9 (ISGF3‑like) response, extending antiviral gene induction.
STAT2 deficiency in humans causes marked susceptibility to viral infections (notably many respiratory RNA viruses, and some DNA viruses), often with severe disease after live‑attenuated vaccines, underscoring STAT2’s non‑redundant role in IFN signaling. Consistently, numerous viruses (e.g., paramyxoviruses, flaviviruses, orthomyxoviruses) encode proteins that degrade, sequester, or block STAT2, highlighting STAT2 as a major target of viral immune evasion.
Because STAT2 tunes IFN pathway amplitude and duration, it represents a potential therapeutic node to enhance antiviral responses or attenuate pathogenic IFN signaling in selected auto‑inflammatory and autoimmune settings.
The AlphaLISA SureFire Ultra Human and Mouse Total STAT2 Detection Kit is a sandwich immunoassay for the quantitative detection of total STAT2 in cellular lysates, using Alpha Technology.
Formats:
AlphaLISA SureFire Ultra kits are compatible with:
AlphaLISA SureFire Ultra kits can be used for:
The Total-AlphaLISA SureFire Ultra assay measures the expression level of a protein target in a cell lysate.
The Total-AlphaLISA SureFire Ultra assay uses two antibodies which recognize two different distal epitopes on the targeted protein. AlphaLISA assays require two bead types: Acceptor and Donor beads. Acceptor beads are coated with a proprietary CaptSure™ agent to specifically immobilize the assay specific antibody, labeled with a CaptSure tag. Donor beads are coated with streptavidin to capture one of the detection antibodies, which is biotinylated. In the presence of targeted protein, the two antibodies bring the Donor and Acceptor beads in close proximity whereby the singlet oxygen transfers energy to excite the Acceptor bead, allowing the generation of a luminescent Alpha signal. The amount of light emission is directly proportional to the quantity of protein present in the sample.
The two-plate protocol involves culturing and treating the cells in a 96-well plate before lysis, then transferring lysates into a 384-well OptiPlate™ plate before the addition of Total-AlphaLISA SureFire Ultra detection reagents. This protocol permits the cells viability and confluence to be monitored. In addition, lysates from a single well can be used to measure multiple targets.
Detection of Total target protein with AlphaLISA SureFire Ultra reagents can be performed in a single plate used for culturing, treatment, and lysis. No washing steps are required. This HTS designed protocol allows for miniaturization while maintaining AlphaLISA SureFire Ultra quality.
A431 cells were seeded in a 96-well plate (60,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2. The cells were treated with increasing concentrations of IFNβ for 30 minutes.
After treatment, the cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). STAT2 Phospho (Tyr690) and Total levels were evaluated using respective AlphaLISA SureFire Ultra assays. For the detection step, 10 µL of cell lysate (approximately 6,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
As expected, IFNβ triggered a dose-dependent increase in the levels of Phospho STAT2 (Tyr690) with a modest decrease in Total levels (2.8 fold).
THP-1 cells were seeded in a 96-well plate (200,000 cells/well) in HBSS containing 10 ng/mL IFNβ for 15 minutes at 37°C, 5% CO2. The cells were then treated with increasing concentrations of JAK inhibitor, Ruxolitinib for a further 1 hour.
After treatment, the cells were spun at 1200 rpm for 5 minutes and lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). STAT2 Phospho (Tyr690) and Total levels were evaluated using respective AlphaLISA SureFire Ultra assays. For the detection step, 10 µL of cell lysate (approximately 20,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
Inhibition of JAK1 signaling mediated by Ruxolitinib, resulted in a decrease of phosphorylated STAT2 after 1 hour while STAT2 Total levels remained unchanged.
Peripheral Blood Mononuclear Cells (PBMCs) were isolated from healthy donors using Ficoll Plaque Plus (Merck GE17-1440-02). PBMCs were lysed at 6 x 106 cells/mL with Lysis Buffer for 10 minutes at RT with shaking. Lysate was serially diluted in Lysis Buffer and evaluated for STAT2 Total levels using the AlphaLISA SureFire Ultra kit.
For the detection step, 10 µL of cell lysate (starting at approximately 60,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings. Dotted line represents assay background.
Adherent cell lines were seeded in a 96-well plate (40,000 cells/well) and incubated overnight at 37°C, 5% CO2. Cells were lysed with 100 µL of Lysis Buffer at RT with shaking (350 rpm). Suspension cell lines were seeded in a 96-well plate (400,000 cells/well) in HBSS + 0.1% BSA and then lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm).
STAT2 levels were evaluated using the AlphaLISA SureFire Ultra assay. For the detection step, 10 µL of cell lysate (approximately 4,000 adherent cells and 40,000 suspension cells) were transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
STAT2 is expressed in a wide variety of cell lines. High levels of expression were detected in PC3, A431 and RPMI 8226 cells.
Cell lysate was prepared from A431 cells cultured to confluency in T175 flasks. Cells were treated with 10 ng/mL IFNβ for 30 minutes and then lysed in 4 mL of Lysis Buffer.
Lysate was serially diluted in Lysis Buffer and STAT2 levels were evaluated using the AlphaLISA SureFire Ultra kit. For the detection step, 10 µL of lysate was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
Approximate number of cells/datapoint is indicated on the graph. The dotted line represents assay background. The assay can detect Total STAT2 in less than 300 cells.
| Application |
Cell Signaling
|
|---|---|
| Automation Compatible |
Yes
|
| Brand |
AlphaLISA SureFire Ultra
|
| Detection Modality |
Alpha
|
| Product Group |
Kit
|
| Protocol Time |
2h at RT
|
| Sample Volume |
10 µL
|
| Shipping Conditions |
Shipped in Blue Ice
|
| Target |
STAT2
|
| Target Class |
Phosphoproteins
|
| Target Species |
Human
Mouse
|
| Technology |
Alpha
|
| Therapeutic Area |
Autoimmunity
Inflammation
Oncology
Virology
|
| Unit Size |
500 Assay Points
|
Are you looking for resources, click on the resource type to explore further.
Alpha technolgy enables the rapid and straightforward mesaure of virtually any target. This includes enzymes, receptor-ligand...
The definitive guide for setting up a successful AlphaLISA SureFire Ultra assay
Several biological processes are regulated by...
Discover Alpha SureFire® Ultra™ assays, the no-wash cellular kinase assays leveraging Revvity's exclusive bead-based technology...
This document includes detailed tables listing HTRF™, AlphaLISA™ SureFire® Ultra™, and Alpha SureFire® Ultra™ Multiplex assays...
Loading...
We are here to answer your questions.